公开(公告)号：EP3458478A1

公开(公告)日：2019-03-27

申请号：EP17726862.0

申请日：2017-05-17

申请人： Boehringer Ingelheim International GmbH

发明人： ZETTL, Markus ,  LORENZ, Ivo ,  SCHAAF, Otmar ,  WURM, Melanie ,  FORTIN, Jean-François ,  BRODEUR, Scott ,  CANADA, Keith A. ,  CHLEWICKI, Lukasz ,  GUPTA, Pankaj ,  GUPTA, Priyanka ,  PEREZ, Rocio K. ,  WOSKA Jr., Joseph Robert ,  XIAO, Haiguang ,  YANG, Danlin

IPC分类号： C07K16/28 ,  A61K39/00

公开(公告)号：EP3848393A1

公开(公告)日：2021-07-14

申请号：EP20216343.2

申请日：2017-05-17

申请人： Boehringer Ingelheim International GmbH

发明人： ZETTL, Markus ,  LORENZ, Ivo ,  SCHAAF, Otmar ,  WURM, Melanie ,  FORTIN, Jean-Francois ,  BRODEUR, Scott ,  CANADA, Keith A. ,  CHLEWICKI, Lukasz ,  DAVIDSON, Walter Carroll ,  GUPTA, Pankaj ,  GUPTA, Priyanka ,  PEREZ, Rocio K. ,  WOSKA Jr., Joseph Robert ,  XIAO, Haiguang ,  YANG, Danlin

IPC分类号： C07K16/28 ,  A61P35/00 ,  A61P43/00 ,  A61K39/00

摘要： The present invention relates to novel anti-PD1 and anti-LAG3 antibody molecules. The invention also relates to nucleic acids encoding such antibody molecules; to methods for preparing such antibody molecules; to host cells expressing or capable of expressing such antibody molecules; to compositions comprising such antibody molecules; and to uses of such antibody molecules or such compositions, in particular for therapeutic purposes in the field of cancer diseases.